Thereasa Rich

6PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 02, 2026
Tumor-Free Circulating Tumor DNA in Node-Negative Rectal Cancers Undergoing Neoadjuvant Chemotherapy, Excision, and Observation in the Phase II NEO Trial (CO.28).

|Jan 30, 2026
Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147).

Frank A Sinicrope, Diana Segovia, Nalin Sharma

|Mar 12, 2025
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium.

Andrew G Hadd, Angela Silvestro, Brittany Avin McKelvey

|Jun 12, 2024
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study.

Susanna Slater, Annette Bryant, Maria Aresu

|May 02, 2024
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.

Aparna R Parikh, Bryant H Chee, Jill Tsai

|Feb 09, 2020
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion BRCA Mutations among Patients with Advanced Solid Tumors.

Neelima Vidula, Thereasa A Rich, Oliver Sartor

Pageof 1

Frequent Collaborators

2 joint publications

Aaron Hardin

2 joint publications

Victoria M Raymond

1 joint publications

Jennifer Yen

1 joint publications

Barbara A Parker